The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism
Open accessAbstract
BACKGROUND: The use of thrombolytic agents in the treatment of hemodynamically stable patients with acute submassive pulmonary embolism remains controversial. METHODS: We conducted a study of patients with acute pulmonary embolism and pulmonary hypertension or right ventricular dysfunction but without arterial hypotension or shock. The patients were randomly assigned in double-blind fashion to receive heparin plus 100 mg of alteplase or heparin plus placebo over a period of two hours. The primary end point was in-hospital death or clinical deterioration requiring an escalation of treatment, which was defined as catecholamine infusion, secondary thrombolysis, endotracheal intubation, cardiopulmonary resuscitation, or emergency surgical embolectomy or thrombus fragmentation by catheter. RESULTS: Of 256 patients enrolled, 118 were randomly assigned to receive heparin plus alteplase and 138 to receive heparin plus placebo. The incidence of the primary end point was significantly higher in the heparin-plus-placebo group than in the heparin-plus-alteplase group (P=0.006), and the probability of 30-day event-free survival (according to Kaplan-Meier analysis) was higher in the heparin-plus-alteplase group (P=0.005). This difference was due to the higher incidence of treatment escalation in the heparin-plus-placebo group (24.6 percent vs. 10.2 percent, P=0.004), since mortality was low in both groups (3.4 percent in the heparin-plus-alteplase group and 2.2 percent in the heparin-plus-placebo group, P=0.71). Treatment with heparin plus placebo was associated with almost three times the risk of death or treatment escalation that was associated with heparin plus alteplase (P=0.006). No fatal bleeding or cerebral bleeding occurred in patients receiving heparin plus alteplase. CONCLUSIONS: When given in conjunction with heparin, alteplase can improve the clinical course of stable patients who have acute submassive pulmonary embolism and can prevent clinical deterioration requiring the escalation of treatment during the hospital stay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goldhaber, S. Z., Visani, L., & De Rosa, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07534-5 · Cited by 2,870
The Clinical Course of Pulmonary Embolism
Carson, J. L., Kelley, M. A., Duff, A., Weg, J. G., Fulkerson, W. J., Palevsky, H. I., Schwartz, J. S., Thompson, B. T., Popovich, J., Hobbins, T. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261902 · Cited by 1,039
Kasper, W., Konstantinides, S., Geibel, A., Olschewski, M., Heinrich, F., Grosser, K. D., Rauber, K., Iversen, S., Redecker, M., & Kienast, J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00319-7 · Cited by 1,034
Self-citationGoldhaber, S. Z., Come, P. C., Lee, R. T., Braunwald, E., Parker, J. A., Haire, W. D., Feldstein, M. L., Miller, M., Toltzis, R., Smith, J. L., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)90274-k · Cited by 849
The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease
McIntyre, K. M., & Sasahara, A. A. (1971) · The American Journal of Cardiology · doi:10.1016/0002-9149(71)90116-0 · Cited by 492
Jerjes-Sanchez, C., Ramírez-Rivera, A., de Lourdes García, M., Arriaga-Nava, R., Valencia, S., Rosado-Buzzo, A., Pierzo, J. A., & Rosas, E. (1995) · Journal of Thrombosis and Thrombolysis · doi:10.1007/bf01062714 · Cited by 485
Echocardiography in the Management of Pulmonary Embolism
Goldhaber, S. Z. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-9-200205070-00012 · Cited by 469
Konstantinides, S., Geibel, A., Olschewski, M., Heinrich, F., Grosser, K., Rauber, K., Iversen, S., Redecker, M., Kienast, J., Just, H., et al. (1997) · Circulation · doi:10.1161/01.cir.96.3.882 · Cited by 462
Self-citationDalla-Volta, S., Palla, A., Santolicandro, A., Giuntini, C., Pengo, V., Visioli, O., Zonzin, P., Zanuttini, D., Barbaresi, F., Agnelli, G., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90002-5 · Cited by 379
Mortality in Patients Treated for Pulmonary Embolism
Alpert, J. S. (1976) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1976.03270140029017 · Cited by 374
Goldhaber, S., Heit, J., Sharma, G. V. R. K., Nagel, J. S., Kim, D., Parker, J. A., Drum, D., Reagan, K., Anderson, J., Kessler, C., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92354-9 · Cited by 367
Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism
Research Committee of the British Thoracic Society (1992) · The Lancet · doi:10.1016/0140-6736(92)93285-u · Cited by 320
Thrombolytic Therapy for Pulmonary Embolism
Kanter, D. S., Mikkola, K. M., Patel, S. R., Parker, J. A., & Goldhaber, S. Z. (1997) · Chest · doi:10.1378/chest.111.5.1241 · Cited by 275
Meyer, G., Sors, H., Charbonnier, B., Kasper, W., Bassand, J.-P., Kerr, I. H., Lesaffre, E., Vanhove, P., & Verstraete, M. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90472-y · Cited by 233
Self-citationGoldhaber, S. Z., Kessler, C. M., Heit, J. A., Elliott, C. G., Friedenberg, W. R., Heiselman, D. E., Wilson, D. B., Parker, J. A., Bennett, D., Feldstein, M. L., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90132-7 · Cited by 220
Comparison of alteplase versus heparin for resolution of major pulmonary embolism
Konstantinides, S., Tiede, N., Geibel, A., Olschewski, M., Just, H., & Kasper, W. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00513-x · Cited by 172
Self-citationLong-term benefit of thrombolytic therapy in patients with pulmonary embolism
Sharma, G. V. R. K., Folland, E. D., McIntyre, K. M., & Sasahara, A. A. (2000) · Vascular Medicine · doi:10.1177/1358836x0000500205 · Cited by 112
THROMBOLYTIC THERAPY FOR VENOUS THROMBOEMBOLISM
Levine, M. N. (1995) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)01095-9 · Cited by 69
Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism.
Miller, G. A., Gc, S., Kerr, I. H., Gibson, R. V., & Honey, M. (1971) · PubMed · Cited by 56
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Self-citationGuidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., Bengel, F., Brady, A. J. B., Ferreira, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn310 · Cited by 2,826
Self-citationJaff, M. R., McMurtry, M. S., Archer, S. L., Cushman, M., Goldenberg, N., Goldhaber, S. Z., Jenkins, J. S., Kline, J. A., Michaels, A. D., Thistlethwaite, P., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214914f · Cited by 2,229
Metadata
- Authors
- Konstantinides, S., Geibel, A., Heusel, G., Heinrich, F., & Kasper, W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-10-10
- Volume
- 347
- Issue
- 15
- Pages
- 1143-1150
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2085984247
- Cited by
- 997
- References
- 19
- FWCI
- 30.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.